Under construction – not a live service
Sign in
Taking people in FranceNo phase

Checking how common heart amyloidosis is in very old heart failure patients

Studies how often heart amyloidosis occurs in people aged 80 or older with heart failure.

Plain-language title generated from the registry record
Registry title: Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

Key facts

Where
Amiens, Angers, Bordeaux, Boulogne-Billancourt, Carcassonne, Castres, Chambray-lès-Tours, Dijon, Grenoble, Issy-les-Moulineaux, Ivry-sur-Seine, Lille, Limeil-Brévannes, Limoges, Lyon, Marseille, Melun, Montpellier, Nancy, Nantes, Nice, Orléans, Paris, Poitiers, Rennes, Rouen, Toulouse, Tours, Trélazé, and Villeurbanne, FranceSee the 36 sites

Where in France

  • Chu Amiens PicardieAmiens, FranceTaking people
  • CHU AngersAngers, FranceTaking people
  • CHU BordeauxBordeaux, FranceTaking people
  • Ambroise Paré HospitalBoulogne-Billancourt, FranceTaking people
  • Centre Hospitalier de CarcassonneCarcassonne, FranceTaking people
  • Centre Hospitalier Intercommunal de Castres MazametCastres, FranceTaking people
  • CHU Trousseau-ToursChambray-lès-Tours, FranceTaking people
  • CHU DijonDijon, FranceTaking people
  • CHU Grenoble AlpesGrenoble, FranceTaking people
  • Corentin Celton HospitalIssy-les-Moulineaux, FranceNot yet recruiting
  • Charles Foix HospitalIvry-sur-Seine, FranceTaking people
  • CHU LilleLille, FranceTaking people
  • Emile Roux HospitalLimeil-Brévannes, FranceTaking people
  • CHU LimogesLimoges, FranceTaking people
  • Chu LyonLyon, FranceTaking people
  • CHU MarseilleMarseille, FranceTaking people
  • GH Sud Ile-de-FranceMelun, FranceTaking people
  • CHU MontpellierMontpellier, FranceTaking people
  • Clinique du Millénaire-MontpellierMontpellier, FranceTaking people
  • CHRU NancyNancy, FranceTaking people
  • CHU NantesNantes, FranceTaking people
  • CHU NiceNice, FranceTaking people
  • Hôpital Privé Gériatrique LES SOURCES-NiceNice, FranceTaking people
  • CHU OrléansOrléans, FranceTaking people
  • Bretonneau HospitalParis, FranceTaking people
  • Europeen Georges Pompidou HospitalParis, FranceTaking people
  • Geriatric Department, Broca HospitalParis, FranceTaking people
  • Lariboisière HospitalParis, FranceTaking people
  • Saint Joseph HospitalParis, FranceTaking people
  • CHU PoitiersPoitiers, FranceTaking people
  • CHU RennesRennes, FranceTaking people
  • CHU Rouen, Charles Nicole hospitalRouen, FranceTaking people
  • CHU ToulouseToulouse, FranceTaking people
  • CHRU Tours-Bretonneau HospitalTours, FranceTaking people
  • Clinique Saint Joseph TrelazeTrélazé, FranceTaking people
  • Médipôle Hôpital Mutualiste VilleurbanneVilleurbanne, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Gérond'if
Trial code
NCT06427304
Record updated
20 April 2026
Original description
Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older hospitalized within the last 12 months for heart failure with left ventricular hypertrophy (septum ≥ 12 mm) on echocardiographyRead full original descriptionShow less

Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older hospitalized within the last 12 months for heart failure with left ventricular hypertrophy (septum ≥ 12 mm) on echocardiography

Inclusion: Aged ≥ 80 years; Hospitalised for decompensation of heart failure in the last 12 months; Subjects with hypertrophy of the septum or left ventricle at cardiac echography (defined as ≥ 12 mm); Subjects able to undergo a bone scintigraphy scan; Subjects willing to participate.

Exclusion: Subjects with a definite diagnosis of cardiac amyloidosis; Subjects refusing to participate; Subjects admitted to palliative care unit; Subjects under guardianship.

ClinicalTrials.gov NCT06427304